论文部分内容阅读
《二甲双胍临床应用专家共识》发布由中国人民解放军总医院内分泌科主任、中华医学会内分泌学分会候任主任委员母义明教授牵头,组织全国34名内分泌临床专家、药学专家共同商讨制订的《二甲双胍临床应用专家共识》在本次会议上公布。该共识进一步肯定了二甲双胍在2型糖尿病治疗中的基石地位,并为广大临床医生及患者对于二甲双胍的使用提出了具有实际意义的推荐和指导。共识于2014年8月发表在《药品评价》第
“Metformin clinical application of expert consensus,” released by the Chinese People’s Liberation Army General Hospital Endocrinology Director, Chinese Medical Association Endocrinology credits will be chairman of the Board led by Professor Yoshihimi, the organization of the country’s 34 endocrine clinical experts and experts in pharmacy to discuss the formulation of “metformin Clinical Expert Advice ”was announced at this meeting. The consensus further affirmed the cornerstone of metformin in the treatment of type 2 diabetes and provided practical recommendations and guidance for the use of metformin by clinicians and patients. Consensus was published in “Medicines Evaluation” in August 2014